Naturally grown high-value compounds for a healthy life
Biomedican – A biotech startup company developed a unique patented method of producing pharmaceutical-grade, 100% organic, non-GMO rare cannabinoids, including
- CBG, CBGA
- THCV, THCVA
- CBN, CBNA
and high-value compounds using a proprietary organic biosynthesis platform at 70-90% lower cost than conventional methods.
Our products
Why choose Biomedican Biotech Company?
Pharmaceutical-grade quality
Pharmaceutical-grade quality
Our patented biosynthetic methods ensure the efficient production of high-quality compounds using the fermentation of unique proprietary yeast. In contrast to chemically synthesized, our natural, organic, non-GMO biosynthetic compounds are 100% identical to those found in nature, while free from undesired by-products.
High-volume production
High-volume production
Some high-value compounds, such as rare cannabinoids, exist in minimal quantities in plants, making their extraction and purification inefficient, costly, and environmentally taxing.
In contrast, yeast fermentation is a fast, highly scalable, and environmentally friendly process, yielding large quantities of a quality product in just a few days instead of months.
In contrast, yeast fermentation is a fast, highly scalable, and environmentally friendly process, yielding large quantities of a quality product in just a few days instead of months.
70-90% lower cost
70-90% lower cost
Our proprietary oily yeast Yarrowia Lipolytica (YL) yields up to 80% of its weight in oils, making it an efficient micro-organism for producing large amounts of target compounds. The fermentation process is cheap and efficient, requiring only sugar, water, and YL yeast, reducing the production costs up to 70-90%.
Pharmaceutical-grade quality
Our patented biosynthetic methods ensure the efficient production of high-quality compounds using the fermentation of unique proprietary yeast. In contrast to chemically synthesized, our natural, organic, non-GMO biosynthetic compounds are 100% identical to those found in nature, while free from undesired by-products.
Pharmaceutical-grade quality
Our patented biosynthetic methods ensure the efficient production of high-quality compounds using the fermentation of unique proprietary yeast. In contrast to chemically synthesized, our natural, organic, non-GMO biosynthetic compounds are 100% identical to those found in nature, while free from undesired by-products.
High-volume production
Some high-value compounds, such as rare cannabinoids, exist in minimal quantities in plants, making their extraction and purification inefficient, costly, and environmentally taxing. In contrast, yeast fermentation is a fast, highly scalable, and environmentally friendly process, yielding large quantities of a quality product in just a few days instead of months.
Pharmaceutical-grade quality
Our patented biosynthetic methods ensure the efficient production of high-quality compounds using the fermentation of unique proprietary yeast. In contrast to chemically synthesized, our natural, organic, non-GMO biosynthetic compounds are 100% identical to those found in nature, while free from undesired by-products.
70-90% lower cost
Our proprietary oily yeast Yarrowia Lipolytica (YL) yields up to 80% of its weight in oils, making it an efficient micro-organism for producing large amounts of target compounds. The fermentation process is cheap and efficient, requiring only sugar, water, and YL yeast, reducing the production costs up to 70-90%.
Pharmaceutical-grade quality
Our patented biosynthetic methods ensure the efficient production of high-quality compounds using the fermentation of unique proprietary yeast. In contrast to chemically synthesized, our natural, organic, non-GMO biosynthetic compounds are 100% identical to those found in nature, while free from undesired by-products.
Contact us
Our story is featured in:
Biosynthesis companies will be able to produce expensive cannabinoids at a much lower price and without fears of contamination. “We can harvest every day, as opposed to a plant that requires 55 days to grow,” says O’Neill.
“When it comes to producing rare cannabinoids, the grow-harvest-extract method is not only costly; it’s unreliable. Instead, the firm uses biosynthesis, a natural process that O’Neill, CIO at Biomedican likens to brewing beer, to grow rare pharmaceutical-grade cannabinoids at scale.”
“Biomedican developed a unique method of cannabinoid biosynthesis production from proprietary yeasts. This process produces high-quality rare cannabinoids without plants, resulting in cheaper, faster, and more sustainable results.”
Biomedican says it will soon be able to produce multiple strains at a similar cost, far below CBG’s current wholesale price of $20 a gram. “This is the next generation of CBD,” O’Neill said.
“Biosynthetic cannabinoid maker Biomedican has also laid out plans to go public in the first half of 2021.”
“Biomedican Inc., based in Fremont, Calif., says it has a strain of CBG ready for widescale production and will ramp up output of another class of minor cannabinoids within two months.”
“Together, these rare cannabinoids will be the new frontier that makes the global cannabis market worth hundreds of billions of dollars. And CBG will be at the forefront of this rare cannabinoid boom.” Maxim Mikheev, CEO and Founder of Biomedican
Invest in leading biotech products
Our patented biosynthetic methods, using yeast fermentation, ensure the efficient production of high-quality compounds.
In contrast to chemically synthesized compounds, our natural, 100% organic, non-GMO biosynthetic products are identical to those extracted from plants while offering higher purity than typically found in nature.
Besides, our unique proprietary yeast is optimized to produce higher quantities of products at a lower cost than competing biosynthetic methods.
